ArticleEuropean journal of pediatrics2022

Risk factors for hospitalisation due to respiratory syncytial virus infection in children receiving prophylactic palivizumab.

Ayako Chida-Nagai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.